Blog

90 articles
lines
All
ASCO GI Reaction
ASH 22 Reactions
Biomarker & CDx
Conference
Culture
ESMO IO '22 reaction
ESMO Reaction
KOL
Podcast
Press
SABCS Reaction
SITC22 Reaction
ASCO GI Reaction
•
January 23, 2023
Top Article

ASCO GI Reaction - SUNLIGHT

Trifluridine/tipiracil plus bevacizumab for third-line treatment of refractory metastatic colorectal cancer: The phase 3 randomized SUNLIGHT study
Read more
Biomarker & CDx
•
August 28, 2020

ESMO – GI 2020

Veri’s data platform's goal is to promote progress in precision oncology by collecting up to date predictive biomarkers of drug response. At EMSO-GI 2020, we presented the advances made in the form of cancer-biomarker-drug associations.

Read more
Biomarker & CDx
•
August 24, 2020

Breakthroughs in Precision Oncology

Precision medicine has rapidly adjusted the oncology diagnostic and treatment spectrum. We examine recent breakthroughs in this space.

Read more
Biomarker & CDx
•
August 5, 2020

Major FDA Approvals in Precision Oncology

Let's look at some of the recent FDA approvals like Merck’s blockbuster drug Keytruda, Genentech's cancer combo drug Phesgo, and some other drugs that have had a major impact on the precision oncology field.

Read more
Biomarker & CDx
•
August 5, 2020

Emerging Biomarkers in Breast Cancer

Well-established biomarkers in breast cancer today include BRCA1/BRCA2, estrogen and progesterone receptors as well as p53, which is the most studied biomarker in breast cancer. Let’s look at some of the biomarkers that are emerging in this space.

Read more
Press
•
June 1, 2020

LARVOL Launches AI-Powered Cancer Data Platform During ASCO 2020

The Larvol Group, a Software as a Service (SaaS) company with 125 employees, announced the launch of Veri, their new decision support and competitive intelligence tool during the 2020 ASCO Annual Meeting...

Read more
Biomarker & CDx
•
April 10, 2020

Top 15 NGS Panels for Cancer

Each expert team needs a panel, but what makes a panel suited to each lab is unique. We took a look at a large universe of NGS panels to help identify what makes panels great.

Read more
Conference
•
September 25, 2019

ASCO 2019 Demographics, Chicago, IL

The ASCO Annual Meeting took place from May 31 – June 4, 2019 in Chicago, IL. ASCO recently released their demographics for 2019 and we are going to compare the numbers from 2018.

Read more
Culture
•
September 13, 2019

Tiger Day 2019

Every year Larvol comes together for Tiger day where we showcase a wide variety of talents from both Larvol Tigers and their families.

Read more
KOL
•
March 11, 2019

LARVOL Launches Omni, Its Next Gen KOL and Pharma Tracking Tool

Larvol, a San Francisco-based pharma SaaS (Software as a Service) company, announced the launch of Omni, their newest Medical Communications and Competitive Intelligence tool at the Medical Affairs Professional Society Annual Conference in New Orleans, LA.

Read more
Culture
•
March 8, 2019

National Telework Week 2019

Larvol has been a fully remote company since day one, to celebrate National Telework Week we've made a video about Larvol's remote culture and share some experiences from our team with working remotely.

Read more
Culture
•
January 1, 2019

Nomad On-the-Go

Hear from our Account Executive, Linh Nguyen, about her experience living as a "digital nomad" while continuing her career with Larvol!

Read more
Culture
•
March 3, 2018

International Women’s Day

Larvol celebrates International Women's Day with a collaborative video showcasing some of the many amazing women here at Larvol.

Read more
SITC22 Reaction
•

SITC22 Reactions - Lifileucel

Lifileucel TIL cell monotherapy in patients with advanced melanoma after progression on immune checkpoint inhibitors (ICI) and targeted therapy: pooled analysis of consecutive cohorts (C-144–01 study)

Read more
No item found
Error
No item found

Subscribe to our newsletter

Sign up for our newsletter to get the latest news, updates and high-impact data delivered directly to your inbox.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Larvo logo footer

Solutions

Services

Resources

Company

LARVOL & SEMPER TIGRIS are registered trademarks in the European Community
Copyright © LARVOL 2023
Privacy PolicyKOL Privacy PolicyAcceptable Use Policy
Waves